Company Description
Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally.
The Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package to treat adults and teens from mild to severe malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years with a mixture of primary/baby and permanent teeth.
This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; as well as Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions.
The Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing (CAD/CAM) software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons.
This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient’s historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services.
The company was incorporated in 1997 and is headquartered in Tempe, Arizona.
| Country | United States |
| Founded | 1997 |
| Industry | Medical Instruments & Supplies |
| Sector | Healthcare |
| Employees | 20,945 |
| CEO | Joseph Hogan |
Contact Details
Address: 410 North Scottsdale Road, Suite 1300 Tempe, Arizona 85288 United States | |
| Phone | 602 742 2000 |
| Website | aligntech.com |
Stock Details
| Ticker Symbol | ALGN |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001097149 |
| CUSIP Number | 016255101 |
| ISIN Number | US0162551016 |
| Employer ID | 94-3267295 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Joseph M. Hogan | President, Chief Executive Officer and Director |
| John F. Morici | Chief Financial Officer and Executive Vice President of Global Finance |
| Julie Ann Coletti J.D. | Executive Vice President and Chief Legal and Regulatory Officer |
| Stuart Hockridge | Executive Vice President of Global Human Resources |
| Emory M. Wright | Executive Vice President of Direct Fabrication Platform and Operations |
| Zelko Relic | Executive Vice President and Chief Technology Officer |
| Shirley Stacy | Vice President of Corporate Communications and Investor Relations |
| Simon Beard | MD for EMEA Region and Executive Vice President |
| Jennifer Olson-Wilk | Executive Vice President and Chief Customer Officer |
| Sreelakshmi Kolli | Executive Vice President and Chief Product and Digital Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 17, 2025 | SCHEDULE 13G/A | Filing |
| Apr 8, 2025 | ARS | Filing |
| Apr 8, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 8, 2025 | DEF 14A | Other definitive proxy statements |
| Mar 27, 2025 | PRE 14A | Other preliminary proxy statements |
| Feb 28, 2025 | 10-K | Annual Report |
| Feb 25, 2025 | 8-K | Current Report |
| Feb 5, 2025 | 8-K | Current Report |
| Jan 27, 2025 | SCHEDULE 13G | Filing |
| Nov 25, 2024 | 144 | Filing |